<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJMM</journal-id><journal-title-group><journal-title>Open Journal of Medical Microbiology</journal-title></journal-title-group><issn pub-type="epub">2165-3372</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojmm.2024.141004</article-id><article-id pub-id-type="publisher-id">OJMM-132113</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Antibiotic Resistance Profile of &lt;i&gt;Enterococcus faecalis&lt;/i&gt; and Enterococcus &lt;i&gt;faecium&lt;/i&gt; Isolates from Urine and Pleural Fluid in Two Hospitals of Cameroon
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cécile</surname><given-names>Ingrid Djuikoue</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Farid</surname><given-names>Wega</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Grace</surname><given-names>Yemina Kombeu</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cedric</surname><given-names>Seugnou Nana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Christiane</surname><given-names>Possi Kiyang</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lussabella</surname><given-names>Pohoko Medzam</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Erica</surname><given-names>Megane Noubissi Makougoum</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nellie</surname><given-names>Mbianga Nkuigoua</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Herman</surname><given-names>Koyouo Tagne</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mérimé</surname><given-names>Joël Tchinda Talokou</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yvonne</surname><given-names>Valérie Yolande Mavoungou</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ashu</surname><given-names>Michel Agbor</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Microbiology Department of the Faculty of Health Sciences of the Université des Montagnes, Bangangté, Cameroon</addr-line></aff><aff id="aff4"><addr-line>Centre Hospitalier Dominicain St Martin de Porres, Yaoundé, Cameroun</addr-line></aff><aff id="aff3"><addr-line>Microbiology Department of the Faculty of Health Sciences of Institut Universitaire du Golf de Guinée, Douala, Cameroon</addr-line></aff><aff id="aff5"><addr-line>Faculté des Sciences de la Santé, Université Marien Ngouabi, Brazzaville, République du Congo</addr-line></aff><aff id="aff2"><addr-line>Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon</addr-line></aff><pub-date pub-type="epub"><day>27</day><month>03</month><year>2024</year></pub-date><volume>14</volume><issue>01</issue><fpage>39</fpage><lpage>49</lpage><history><date date-type="received"><day>16,</day>	<month>November</month>	<year>2023</year></date><date date-type="rev-recd"><day>25,</day>	<month>March</month>	<year>2024</year>	</date><date date-type="accepted"><day>28,</day>	<month>March</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  &lt;i&gt;&lt;span style=&quot;font-size:10.0pt;font-family:;&quot; &quot;=&quot;&quot;&gt;Enterococcus&lt;/span&gt;&lt;/i&gt;&lt;span style=&quot;font-size:10.0pt;font-family:;&quot; &quot;=&quot;&quot;&gt; &lt;i&gt;faecalis&lt;/i&gt; and &lt;i&gt;Enterococcus&lt;/i&gt; &lt;i&gt;faecium&lt;/i&gt; rank among the leading causes of nosocomial bacteremia and urinary tract infections. They often persist on hospital surfaces due to their ability to withstand adverse environmental conditions (low or high temperatures, high pH, &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt;font-family:;&quot; &quot;=&quot;&quot;&gt;and &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt;font-family:;&quot; &quot;=&quot;&quot;&gt;high salinity). The global &lt;i&gt;Enterococcus&lt;/i&gt; &lt;i&gt;faecalis&lt;/i&gt;-&lt;i&gt;Enterococcus&lt;/i&gt; &lt;i&gt;faecium&lt;/i&gt; ratio is currently shifting towards &lt;i&gt;Enterococcus&lt;/i&gt; &lt;i&gt;faecium&lt;/i&gt;. &lt;i&gt;Enterococci&lt;/i&gt; present variable levels of resistance to certain families of antibiotics&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt;font-family:;&quot; &quot;=&quot;&quot;&gt;.&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt;font-family:;&quot; &quot;=&quot;&quot;&gt; This is the case for aminoglycosides, beta-lactams and cephalosporins. In 2017, WHO ranked &lt;i&gt;Enterococci&lt;/i&gt; among priority pathogens for research and development of new antibiotics. The objective of our study was to determine the antibiotic resistance profile of &lt;i&gt;Enterococcus&lt;/i&gt; &lt;i&gt;faecalis&lt;/i&gt; and &lt;i&gt;Enterococcus&lt;/i&gt; &lt;i&gt;faecium&lt;/i&gt; isolates from urine and pleural fluid in two hospitals &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt;font-family:;&quot; &quot;=&quot;&quot;&gt;in&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt;font-family:;&quot; &quot;=&quot;&quot;&gt; Cameroon. This cross-sectional and analytic study was carried out between June to August 2023 on hospitalized and day patients in which a cytobacteriological test of urine and pleural fluid was don&lt;span&gt;e. The samples were inoculated on CLED Agar for urine and on Chocolate + polyvitex and blood agar (prepared from Columbia agar) for pleural fluid samples and incubated at 37&lt;/span&gt;&lt;span style=&quot;font-family:宋体;font-size:10pt;&quot;&gt;℃&lt;/span&gt;&lt;span&gt;&amp;nbsp;for 18 to 24 hours. Identification of isolates was carried out using the API 20 STREP micro gallery (Biomerieux, France) and tested for antimicrobial susceptibility. The data on socio-demographical and potential risk factors were recorded using self-administered questionnaires and data from laboratory analyses of the speci&lt;/span&gt;men were collected in a data capture sheet. Potential risk factors associated with the presence of &lt;i&gt;Enterococci&lt;/i&gt;, were evaluated using the logistic regression in univariate and multivariate analysis. P value &amp;lt; 0.05 was considered as significant. A total of 511 patients were recruited who were predominantly females. &lt;i&gt;Enterococcus&lt;/i&gt; &lt;i&gt;spp&lt;/i&gt; were isolated in 27.79% of our samples with &lt;i&gt;Enterococcus&lt;/i&gt; &lt;i&gt;faecalis&lt;/i&gt; mostly encountered. &lt;i&gt;Enterococcus&lt;/i&gt; spp showed &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt;font-family:;&quot; &quot;=&quot;&quot;&gt;a &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt;font-family:;&quot; &quot;=&quot;&quot;&gt;high level of resistance&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt;font-family:;&quot; &quot;=&quot;&quot;&gt; &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt;font-family:;&quot; &quot;=&quot;&quot;&gt;to penicilline (99.3% to Ampicilline), macrolides (66.2% to Erythromycin) and cyclines (85.2% to Doxycycline). Hospitalisation, access to health facilities, contact with urine specimen and hand hygiene practices were risk factors related to infection with &lt;i&gt;Enterococcus&lt;/i&gt; &lt;i&gt;spp&lt;/i&gt; while hospitalisation, health facility and hand hygiene were&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt;font-family:;&quot; &quot;=&quot;&quot;&gt; &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt;font-family:;&quot; &quot;=&quot;&quot;&gt;related to glycopeptide resistant &lt;i&gt;Enterococcus&lt;/i&gt;. Strict compliance with hygiene rules and appropriate antibiotic consumption could help in the fight against these infections.&lt;/span&gt;
 
</p></abstract><kwd-group><kwd>&lt;i&gt;Enterococcus faecalis&lt;/i&gt;</kwd><kwd> &lt;i&gt;Enterococcus faecium&lt;/i&gt;</kwd><kwd> Healthcare-Associated  Infections</kwd><kwd> Antimicrobial Resistance</kwd><kwd> Cameroon</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Enterococci are facultative anaerobic Gram-positive bacteria, immobile and non-encapsulated, present in the digestive tract of animals and humans [<xref ref-type="bibr" rid="scirp.132113-ref1">1</xref>] . Some species are useful in the manufacture of dairy products, playing a role in the conservation and bacteriological quality of food while maintaining their nutritional and organoleptic properties. But others are often opportunistic and cause infections in adults and newborns especially Enterococcus faecalis and Enterococcus faecium which rank among the leading causes of nosocomial bacteremia and urinary tract infections [<xref ref-type="bibr" rid="scirp.132113-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.132113-ref3">3</xref>] . They often persist on hospital surfaces due to their ability to withstand adverse environmental conditions (low or high temperatures, high pH, and high salinity). The global Enterococcus faecalis—Enterococcus faecium ratio is currently shifting towards Enterococcus faecium. The acquired antibiotic resistance traits of this latter species can explain this evolution [<xref ref-type="bibr" rid="scirp.132113-ref4">4</xref>] .</p><p>The advent of antibiotic therapy in the 1940s allowed a significant evolution in the management of infectious diseases. Unfortunately, antimicrobial resistance has quickly become a global health problem [<xref ref-type="bibr" rid="scirp.132113-ref5">5</xref>] . Enzymatic inhibition, reducing membrane permeability, modification of antibiotic targeted binding sites and the production of efflux pumps are some of the mechanisms used by organisms to fight against antibiotics. Some of the main reasons for antimicrobial resistance are self-medication, incorrect use of antibiotics (wrong dosage and prolonged use), lack of standards for health workers and misuse in animal husbandry [<xref ref-type="bibr" rid="scirp.132113-ref5">5</xref>] .</p><p>Enterococci present variable resistance levels to some antibiotics. This is the case for aminoglycosides, beta-lactams and cephalosporins [<xref ref-type="bibr" rid="scirp.132113-ref6">6</xref>] . In 2017, WHO ranked Enterococci among priority pathogens for research and development of new antibiotics. In America, a study carried out by Faron et al., in 2016 indicated that the prevalence of vancomycin-resistant Enterococci (VRE) over the past decade was increasing [<xref ref-type="bibr" rid="scirp.132113-ref7">7</xref>] . In 2015 Abamecha et al.; in Ethiopia evaluated the resistance profile of Enterococci and demonstrated that 36% of the isolated strains were resistant to ampicillin, 54.4% to streptomycin and 34.2% to gentamycin [<xref ref-type="bibr" rid="scirp.132113-ref8">8</xref>] . While in Algeria, Benzaid et al., in 2022 reported a prevalence of 7.81% of nosocomial infections due to Enterococcus faecalis [<xref ref-type="bibr" rid="scirp.132113-ref9">9</xref>] . In Cameroon, a study conducted in 2015 by Gonsu et al.; on the antibiotic sensitivity profile of Enterococci showed that 94% of Enterococcus faecalis strains were resistant to erythromycin, 59% to trimethoprim + sulfonamides and 53% to tetracycline. They stated that the majority of strains were isolated from 72% of hospitalized patients, and 27.58% of non-hospitalized patients [<xref ref-type="bibr" rid="scirp.132113-ref10">10</xref>] .</p><p>However, few studies have been carried out in Cameroon to fully understand the burden of antibiotic resistance as a result of Enterococci in hospital acquired infections. Therefore, the objective of our study was to determine the antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolates from urine and pleural fluid in two hospitals of Cameroon.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Study Duration and Location</title><p>A cross-sectional descriptive, laboratory and analytical study was carried out between June to August 2023 in two public hospitals; One in the Centre region (Saint Porres Dominican Hospital Center) and the other in Littoral region (Laquintinie hospital of Douala). Sampling and analysis was done in the laboratories of both hospitals.</p></sec><sec id="s2_2"><title>2.2. Sampling Method and Study Population</title><p>Our study population included all hospitalized and non-hospitalized patients which a cytobacteriological test of urine and pleural fluid were done. The minimum sample size was obtained using the Lorentz formula. Data related to potential risk factors were collected using a questionnaire.</p></sec><sec id="s2_3"><title>2.3. Sample Analysis</title><p>The samples were inoculated on CLED Agar for urine and on Chocolate + polyvitex and blood agar (prepared from Columbia agar) for pleural fluid samples and incubated at 37˚C for 18 to 24 hours. Identification of isolates was carried out using the API 20 STREP micro gallery (Biomerieux, France) and tested for antimicrobial susceptibility.</p></sec><sec id="s2_4"><title>2.4. Antibiotic Susceptibility Testing</title><p>All isolates of Enteroccocus spp confirmed were inoculated using a bacterial inoculum (following the 0.5McFarland standard) on M&#252;eller-Hinton medium and incubated for 24 hours at 37˚C in order to test their sensitivities to different families of antibiotics using the agar diffusion method. The interpretation was made according to the Antibiogram Committee of the French Society of Microbiology (CA-SFM-2023 v.1.0). We used 11 different antibiotic discs per strain: Ampicillin (2 &#181;g), Gentamicin (30 &#181;g), Vancomycin (5 &#181;g), Teicoplanin (30 &#181;g), Doxycycline, cotrimoxazole (1.25/23.75 &#181;g), Erythromycin (15 &#181;g), Streptomycin (300 &#181;g), Norfloxacin (10 &#181;g), Rifampicin (5 &#181;g), and Imipenem (10 &#181;g). The detection of Enteroccocus isolates resistant to glycopeptides was done by observing the reduced inhibition diameter around the Vancomycin and Teicoplanin disks.</p></sec><sec id="s2_5"><title>2.5. Data Evaluation and Analysis</title><p>The data on socio-demographical and potential risk factors were recorded on the Microsoft Excel 2016 software and analysed using Epi info version 7.0. The results were expressed using descriptive statistics and associated to their confidence interval at 95%. The research of potential risk factors associated to the presence of Enterococci, was done using the logistic regression in univariate and multivariate analysis. P value &lt; 0.05 was considered as significant.</p></sec><sec id="s2_6"><title>2.6. Ethical Considerations</title><p>An ethical clearance was obtained on the basis of the evaluation and validation of the research protocol by the Institutional Ethics Committee of Universit&#233; des Montagnes (Autorisation N˚ 2023/176/UdM/PR/CEAQ). Free and informed consent of patients were obtained and sample collection authorizations were equally obtained from the two hospitals.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Sociodemographic Characteristics of the Study Population</title><p>A total of 511 patients made up of (63.99%). females were recruited for the study. The majority 90.22% of the patients were not hospitalised and 80.63% had not consumed antibiotics for at least two weeks. Our specimen were mostly made up of wound (67.71%) (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s3_2"><title>3.2. Distribution of Enterococcus spp Infection among Patients</title><p>Enterococcus spp were isolated in 27.79% of our samples with Enterococcus faecalis mostly encountered (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p></sec><sec id="s3_3"><title>3.3. Antibiotic Resistant Pattern of Enterococcus spp Isolates</title><sec id="s3_3_1"><title>3.3.1. Antibiotic Susceptibility Testing</title><p>Enterococcus spp showed high level of resistances to penicilline (99.3% to Ampicilline), macrolides (66.2% to Erythromycin) and cyclines (85.2% Doxycycline) (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Eleven antibiotics were tested following EUCAST 2023.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of the study population according to their socio-demographic characteristics</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variable</th><th align="center" valign="middle"  rowspan="2"  >Categories</th><th align="center" valign="middle"  colspan="2"  >Frequency</th></tr></thead><tr><td align="center" valign="middle" >n</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Age (years)</td><td align="center" valign="middle" >&lt;30</td><td align="center" valign="middle" >127</td><td align="center" valign="middle" >24.85</td></tr><tr><td align="center" valign="middle" >[30 - 49[</td><td align="center" valign="middle" >221</td><td align="center" valign="middle" >43.25</td></tr><tr><td align="center" valign="middle" >≥50</td><td align="center" valign="middle" >163</td><td align="center" valign="middle" >31.90</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Sex</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >327</td><td align="center" valign="middle" >63.99</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >184</td><td align="center" valign="middle" >36.01</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Scholar level</td><td align="center" valign="middle" >Primary</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >3.13</td></tr><tr><td align="center" valign="middle" >Secondary</td><td align="center" valign="middle" >145</td><td align="center" valign="middle" >28.38</td></tr><tr><td align="center" valign="middle" >University</td><td align="center" valign="middle" >350</td><td align="center" valign="middle" >68.49</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Marital status</td><td align="center" valign="middle" >Single</td><td align="center" valign="middle" >262</td><td align="center" valign="middle" >51.27</td></tr><tr><td align="center" valign="middle" >Married</td><td align="center" valign="middle" >249</td><td align="center" valign="middle" >48.73</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Health facility</td><td align="center" valign="middle" >Laquintinie</td><td align="center" valign="middle" >252</td><td align="center" valign="middle" >49.32</td></tr><tr><td align="center" valign="middle" >CHDSMP</td><td align="center" valign="middle" >259</td><td align="center" valign="middle" >50.68</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Occupation</td><td align="center" valign="middle" >Student</td><td align="center" valign="middle" >142</td><td align="center" valign="middle" >27.79</td></tr><tr><td align="center" valign="middle" >Worker</td><td align="center" valign="middle" >369</td><td align="center" valign="middle" >72.21</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Hospitalised</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >461</td><td align="center" valign="middle" >90.22</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >9.78</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Specimen</td><td align="center" valign="middle" >Blood</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >1.76</td></tr><tr><td align="center" valign="middle" >Wound</td><td align="center" valign="middle" >346</td><td align="center" valign="middle" >67.71</td></tr><tr><td align="center" valign="middle" >Urine</td><td align="center" valign="middle" >156</td><td align="center" valign="middle" >30.53</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Antibiotic consumption ≤2 weeks</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >412</td><td align="center" valign="middle" >80.63</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >99</td><td align="center" valign="middle" >19.37</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Hand hygiene</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >127</td><td align="center" valign="middle" >24.85</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >384</td><td align="center" valign="middle" >75.15</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >511</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap></sec><sec id="s3_3_2"><title>3.3.2. Prevalence of Glycopeptide Resistant Enterococcus</title><p>A few 6.65% of Enterococcus spp isolates were resistant to Glycopeptide (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p></sec></sec><sec id="s3_4"><title>3.4. Analysis of Risk Factors Related to Infection with Enterococcus spp</title><p>Risk factors related to infection with Enterococcus spp were sought with a 95% confidence interval. P-values were significant for values less than 0.05 (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>Hospitalization, Health facility, type of urine specimen and hand hygiene were risk factors related to infection with Enterococcus spp.</p></sec><sec id="s3_5"><title>3.5. Univariate Analysis of Risk Factors to Glycopeptide Resistant Enterococcus spp Infection</title><p>Risk factors to glycopeptide resistant Enterococcus spp were sought with a 95% confidence interval. P-values were significant for values less than 0.05 Hospitalization, health facility and hand hygiene were risk factors related to glycopeptide resistant Enterococcus spp (<xref ref-type="table" rid="table3">Table 3</xref>).</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>The current study highlights the significance of the fight against antibiotic resistance, contribute to the care of patients suffering from multi-resistant bacteria and reduce nosocomial infections. The study revealed a high frequency of Enterococcus faecium mostly encountered as compared to Enterococcus infection with significant resistance to 11 antibiotics.</p><p>The average age of the participants in the current study was 35 years given that the African population is mainly made up of young people. Furthermore, our participants were predominantly women (66.99%) than men (36.01%). This is explained by the fact that women are more exposed to urinary infections due to the anatomical particularities of the urinary system; their urethra is shorter, making it easier for bacteria to enter the bladder [<xref ref-type="bibr" rid="scirp.132113-ref11">11</xref>] .</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Univariate analysis of risk factors related to Enterococcus spp infection</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" ></th><th align="center" valign="middle" >GRE n (%)</th><th align="center" valign="middle" >OR (CI95%)</th><th align="center" valign="middle" >P-value</th></tr></thead><tr><td align="center" valign="middle"  rowspan="3"  >Age (years)</td><td align="center" valign="middle" >&lt;30</td><td align="center" valign="middle" >10 (7.87)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Ref</td></tr><tr><td align="center" valign="middle" >[30 - 49[</td><td align="center" valign="middle" >17 (7.69)</td><td align="center" valign="middle" >0.97 (0.43 - 2.20)</td><td align="center" valign="middle" >0.95</td></tr><tr><td align="center" valign="middle" >≥50</td><td align="center" valign="middle" >7 (4.29)</td><td align="center" valign="middle" >0.52 (0.19 - 1.42)</td><td align="center" valign="middle" >0.20</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Sex</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >20 (6.12)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Ref</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >14 (7.61)</td><td align="center" valign="middle" >1.26 (0.62 - 2.57)</td><td align="center" valign="middle" >0.52</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Scholar level</td><td align="center" valign="middle" >Primary</td><td align="center" valign="middle" >0 (0.00)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Secondary</td><td align="center" valign="middle" >12 (8.28)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Ref</td></tr><tr><td align="center" valign="middle" >University</td><td align="center" valign="middle" >22 (6.29)</td><td align="center" valign="middle" >0.74 (0.36 - 1.54)</td><td align="center" valign="middle" >0.43</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Marital status</td><td align="center" valign="middle" >Single</td><td align="center" valign="middle" >17 (6.49)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Ref</td></tr><tr><td align="center" valign="middle" >Married</td><td align="center" valign="middle" >17 (6.83)</td><td align="center" valign="middle" >1.06 (0.53 - 2.12)</td><td align="center" valign="middle" >0.88</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Professional category</td><td align="center" valign="middle" >Student</td><td align="center" valign="middle" >8 (5.63)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Ref</td></tr><tr><td align="center" valign="middle" >Worker</td><td align="center" valign="middle" >26 (7.05)</td><td align="center" valign="middle" >1.27 (0.56 - 2.87)</td><td align="center" valign="middle" >0.57</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Hospitalised</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >23 (4.99)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Ref</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >11 (22.00)</td><td align="center" valign="middle" >5.37 (2.44 - 11.83)</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Health facility</td><td align="center" valign="middle" >Laquintinie</td><td align="center" valign="middle" >9 (3.57)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Ref</td></tr><tr><td align="center" valign="middle" >CHDSMP</td><td align="center" valign="middle" >25 (9.65)</td><td align="center" valign="middle" >2.88 (1.32 - 6.31)</td><td align="center" valign="middle" >0.01</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Specimen</td><td align="center" valign="middle" >Blood</td><td align="center" valign="middle" >0 (0.00)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Ref</td></tr><tr><td align="center" valign="middle" >Wound</td><td align="center" valign="middle" >17 (4.91)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Ref</td></tr><tr><td align="center" valign="middle" >Urine</td><td align="center" valign="middle" >17 (10.90)</td><td align="center" valign="middle" >2.37 (1.17 - 4.77)</td><td align="center" valign="middle" >0.01</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Antibiotic consumption ≤2 weeks</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >27 (6.55)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Ref</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >7 (7.07)</td><td align="center" valign="middle" >1.08 (0.46 - 2.57)</td><td align="center" valign="middle" >0.85</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Hand hygiene</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >19 (4.95)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Ref</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >15 (11.81)</td><td align="center" valign="middle" >2.57 (1.27 - 5.23)</td><td align="center" valign="middle" >0.01</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Specie</td><td align="center" valign="middle" >E. faecalis</td><td align="center" valign="middle" >14 (29.17)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Ref</td></tr><tr><td align="center" valign="middle" >E. faecium</td><td align="center" valign="middle" >20 (21.28)</td><td align="center" valign="middle" >0.66 (0.30 - 1.45)</td><td align="center" valign="middle" >0.30</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Univariate analysis of risk factors to glycopeptide resistant Enterococcus spp infection</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" ></th><th align="center" valign="middle" >Adj OR (CI 95%)</th><th align="center" valign="middle" >P-value</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >Hospitalised</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Ref</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >4.44 (1.97 - 9.96)</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Health facility</td><td align="center" valign="middle" >Laquintinie</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >CHDSMP</td><td align="center" valign="middle" >2.38 (1.07 - 5.31)</td><td align="center" valign="middle" >0.03</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Specimen</td><td align="center" valign="middle" >Wound</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Ref</td></tr><tr><td align="center" valign="middle" >Urine</td><td align="center" valign="middle" >1.40 (0.64 - 3.05)</td><td align="center" valign="middle" >0.40</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Hand hygiene</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Ref</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >2.18 (01.05 - 4.53)</td><td align="center" valign="middle" >0.04</td></tr></tbody></table></table-wrap><p>The Enterococcus spp were isolated in 27.79% of our samples. This result is higher than the 8.44% found by Akhter et al. in Tunisia in 2014 in which they isolated Enterococci from urine only [<xref ref-type="bibr" rid="scirp.132113-ref12">12</xref>] . Enterococci ranks among the leading bacteria responsible for urinary tract infection [<xref ref-type="bibr" rid="scirp.132113-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.132113-ref14">14</xref>] .</p><p>In the current study, E. faecium predominates over E. faecalis (66.2%); these results are similar to those of Gonsu et al.; who also demonstrated the predominance of 52% of E. faecium [<xref ref-type="bibr" rid="scirp.132113-ref10">10</xref>] . Recent studies have demonstrated that the worldwide ratio of Enterococcus faecalis—Enterococcus faecium is changing in favor of E. faecium due to the Intrinsic and acquired antimicrobial resistance traits of this species [<xref ref-type="bibr" rid="scirp.132113-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.132113-ref16">16</xref>] .</p><p>The antibiotic susceptibility testing of the current study revealed of a strong resistance to penicillins, tetracyclines, and macrolides. This is similar to that of Muylaert and Mainil who reported this resistance to macrolides, tetracycline betalactams. Intrinsic resistance to beta lactams is maintained in Enterococci through the overproduction of penicillin binding proteins. Concerning aminoglycoside resistance, the low permeability of the well to the large aminoglycoside molecules could explain the moderate resistance [<xref ref-type="bibr" rid="scirp.132113-ref17">17</xref>] . Furthermore, 6.65% of Enterococcus spp isolates were resistant to Glycopeptide. Resistance to glycopeptides is mainly the result of the presence of resistance genes carried by plasmids. The most common being vanA, vanB and vanC [<xref ref-type="bibr" rid="scirp.132113-ref18">18</xref>] .</p><p>The univariate analysis of risk factors in our study allowed us to highlight the main factors linked to infection due to Enterococcus spp such as hospitalization (OR = 5.37; P-value = 0.00), hand hygiene (OR = 2.57; P-value = 0.01) and the specimen type (OR = 2.37; P-value = 0.01). Our results corroborate with a similar study carried out by Stucki et al. in Switzerland in 2014 [<xref ref-type="bibr" rid="scirp.132113-ref19">19</xref>] . These values could be explained on the one hand by the fact that when hygiene and environmental conditions are not favorable, the promiscuity of patients in hospital rooms favors transmissible infections; during their stay at the hospital, patients are exposed to bacteria through several sources including infected patients especially when hygiene rules are not respected [<xref ref-type="bibr" rid="scirp.132113-ref20">20</xref>] . On the other hand, the length of stay hospital is also a factor because the more a hospitalized person is bedridden, the more they are exposed to the risk of infections due to Enterococcus spp [<xref ref-type="bibr" rid="scirp.132113-ref21">21</xref>] . These factors were equally linked to glycopeptide resistant Enterococcus.</p></sec><sec id="s5"><title>5. Conclusions</title><p>Our study revealed that the frequency of Enterococcus infection was 27.79% with Enterococcus faecium mostly encountered (66.2%). Significant resistance to penicillin (99.3% Ampicillin), macrolides (66.2% Erythromycin) and cyclines (85.2% Doxycycline) were observed. Equally, 6.65% of Enterococcus spp isolates were resistant to Glycopeptide.</p><p>Risk factors related to infection with Enterococcus spp were related to the type of health facility, urine specimen and hand hygiene practices while risk factors related to infection with Enterococcus spp were hospitalisation, health facility and hand hygiene being related to glycopeptide resistant Enterococcus.</p></sec><sec id="s6"><title>Acknowledgements</title><p>Our thanks go to all those who contributed to this research study.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>Authors declare no competing interests.</p></sec><sec id="s8"><title>Authors’ Contributions</title><p>Conceptualization: CID; Project administration: CID, and AMA; Resources: CID, LPM, EMNM, NMN; Methodology: CID, FW, GYK, CSN, CPK, LPM, EMNM, NMN and AMA; Investigation: FW, GYK, CSN, CPK, LPM, EMNM, NMN, HKT, MJTT, and YVYM; software: CID, and CSN; Formal analysis: CSN and FW; Visualization: CID, and AMA; Writing-original draft: CID, FW, GYK, and CPK; Writing-review and editing: CID, FW, and CSN; Validation: CID, and AMA; Supervision: AMA; Data curation: CID. All authors have read and agreed to the published version of the manuscript.</p></sec><sec id="s9"><title>Cite this paper</title><p>Djuikoue, C.I., Wega, F., Kombeu, G.Y., Nana, C.S., Kiyang, C.P., Medzam, L.P., Makougoum, E.M.N., Nkuigoua, N.M., Tagne, H.K., Talokou, M.J.T., Mavoungou, Y.V.Y. and Agbor, A.M. (2024) Antibiotic Resistance Profile of Enterococcus faecalis and Enterococcus faecium Isolates from Urine and Pleural Fluid in Two Hospitals of Cameroon. Open Journal of Medical Microbiology, 14, 39-49. https://doi.org/10.4236/ojmm.2024.141004</p></sec></body><back><ref-list><title>References</title><ref id="scirp.132113-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Kacimi, A.G. and Ouazi, T. (2017) Caractérisation phénotypique des souches d’entérocoques isolées des produits alimentaires. Thèse de doctorat, Université Mouloud Mammeri de Tizi-Ouzou, Tizi-Ouzou.</mixed-citation></ref><ref id="scirp.132113-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Laurence, S., Petignat, C., Charbanel, D., et al. (2013) Contr&amp;#244;le d’une épidémie d’entérocoques résistants à la vancomycine dans plusieurs h&amp;#244;pitaux de Suisse Romande. Revue Médicale Suisse, 9, 890-893.</mixed-citation></ref><ref id="scirp.132113-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Aguilar, G., Ana, C., Dubois, D., et al. (2012) Les enterocoques: Avantages et inconvénients en biotechnologie (synthèse bibliographique). Biotechnologie, Agronomie, Société et Environnement, 16, 67-76.</mixed-citation></ref><ref id="scirp.132113-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Cattoir, V. and Giard, J. (2014) Antibiotic Resistance in Enterococcus faecium Clinical Isolate. Expert Review of Anti-Infective Therapy, 12, 239-248. https://doi.org/10.1586/14787210.2014.870886</mixed-citation></ref><ref id="scirp.132113-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Agbor, M.A. and Azodo, C.C. (2011) Self Medication for Oral Health Problems in Cameroon. International Dental Journal, 61, 204-209. https://doi.org/10.1111/j.1875-595X.2011.00058.x</mixed-citation></ref><ref id="scirp.132113-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Deboscker, S. (2019) Les entérocoques résistants aux glycopeptides: épidémiologie et modélisation de leur transmission hospitalière. Thèse de doctorat, Université de Strasbourg, Strasbourg.</mixed-citation></ref><ref id="scirp.132113-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Faron, L., Ledeboer, A. and Buchan, W. (2016) Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting. Journal of Clinical Microbiology, 54, 2436-2447. https://doi.org/10.1128/JCM.00211-16</mixed-citation></ref><ref id="scirp.132113-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Abamecha, A., Wondafrash, B. and Abdissa, A. (2015) Profil de résistance aux antimicrobiens des espèces d’Entérococcus isolées des voies intestinales des patients hospitalisés è Jimma, En Ethiopie. Notes de Recherche du BMC, 8, Article No. 213. https://doi.org/10.1186/s13104-015-1200-2</mixed-citation></ref><ref id="scirp.132113-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Benzaid, C., Tichati, L., Rouabhia, M. and Akil Dahdouh, S. (2022) Prevalence of Microbial Nosocomial Infections in the Resuscitation Unit of the University of Annaba-Algeria. Annales de Biologie Clinique, 80, 527-536. https://doi.org/10.1684/abc.2022.1766</mixed-citation></ref><ref id="scirp.132113-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Kamga, G., Gueye, M., Jackson, S., Toukam, M., et al. (2015) Résistance aux antibiotiques des entérocoques responsables des infections urinaires au Centre Hospitalier et Universitaire de Yaoundé (Cameroun). African Journal of Pathologie and Microbiologie, 4, 1-5. https://doi.org/10.4303/ajpm/235913</mixed-citation></ref><ref id="scirp.132113-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Mbuya, K., Twite, K., Nkana, M., Mujing, F., Kasamba, I. and Kalenga, M. (2020) Profil bactériologique des infections urinaires diagnostiquées aux cliniques universitaires de Lubumbashi-RDC. IOSR-JDMS, 19, 1-8.</mixed-citation></ref><ref id="scirp.132113-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Jabin, A., Sharmeen, A. and Shaheda, A. (2014) Antimicrobial Susceptibility Patterns of Enterococcus Species Isolated from Urinary Tract Infections. Bangladesh Journal of Medical Microbiology, 8, 16-20.</mixed-citation></ref><ref id="scirp.132113-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Khan, A., Miller, R., Axell-House, D., Munita, M. and Arias, A. (2022) Antimicrobial Susceptibility Testing for Enterococci. Journal of Clinical Microbiology, 60, e0084321. https://doi.org/10.1128/jcm.00843-21</mixed-citation></ref><ref id="scirp.132113-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Sreeja, S., Sreenivasa, B. and Prathab, A.G. (2012) La prévalence et la caractérisation des espèces d’entérocoques à partir de divers échantillons cliniques dans un h&amp;#244;pital de soins tertiaires. Journal de Recherche Clinique et Diagnostique: JCDR, 6, Article 1486.</mixed-citation></ref><ref id="scirp.132113-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Weisser, M. and Widmer, A. (2012) Entérocoques Multirésistants. Forum Médical Suisse, 12, 805-807.</mixed-citation></ref><ref id="scirp.132113-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Lukuke, H.M., Kasamba, E. and Mahuridi, A. (2017) L’incidence des infections nosocomiales urinaires et des sites opératoires dans la maternité de l’H&amp;#244;pital Général de Référence de Katuba à Lubumbashi en République Démocratique du Congo. Pan African Medical Journal, 28, Article No. 57. https://doi.org/10.11604/pamj.2017.28.57.9866</mixed-citation></ref><ref id="scirp.132113-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Muylaert, A. and Mainil, J. (2013) Résistance bactériennes aux antibiotiques, Es mécanismes et leur contagiosité. Annales de Médecine Vétérinaire, 156, 109-123.</mixed-citation></ref><ref id="scirp.132113-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">O’Driscoll, T. and Crank, C.W. (2015) Vancomycin-Resistant Enterococcal Infections: Epidemiology, Clinical Manifestations and Optimal Management. Infection and Drug Resistance, 8, 217-230. https://doi.org/10.2147/IDR.S54125</mixed-citation></ref><ref id="scirp.132113-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Stucki, K., Nendaz, M. and Harbarth, S. (2014) Infections à Entérocoques: Du plus simple au plus complexe. Revue Médicale Suisse, 10, 1918-1923.</mixed-citation></ref><ref id="scirp.132113-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Dadfarma, N., Imani, F.A.A., Oskoui, M. and Mahmoodzadeh, H.H. (2013) High Level of Gentamicin Resistance (HLGR) among Enterococcus Strains Isolated from Clinical Specimens. Journal of Infection and Public Health, 6, 202-208. https://doi.org/10.1016/j.jiph.2013.01.001</mixed-citation></ref><ref id="scirp.132113-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Hassan, A.K., Fatima, K.B. and Riffat, M. (2017) Nosocomial Infections: Epidemiology, Prevention, Control and Surveillance. Asian Pacific Journal of Tropical Biomedicine, 7, 478-482. https://doi.org/10.1016/j.apjtb.2017.01.019</mixed-citation></ref></ref-list></back></article>